Coagulation Factor Concentrates Market
Coagulation Factor Concentrates Market Analysis By Type (Coagulation Factor IX, Coagulation Factor XIII & Other Types) By End-User (Hospitals & Clinics, Research Laboratories & Academic Institutions) By Region – Global Market Insights 2022 to 2027
Analysis of Coagulation Factor Concentrates market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Coagulation Factor Concentrates Market Outlook (2022 to 2027)
In 2022, the global coagulation factor concentrates market is valued at US$ 7.8 billion and is predicted to climb to US$ 11.4 billion by the end of 2027. Worldwide demand for coagulation factor concentrates is anticipated to rise at a high-value CAGR of 7.8% over the next five years.
Coagulation factor XIII is anticipated to witness high demand owing to the rising incidence of hemophilia and its better-quality safety profile than other factor concentrates.
| Report Attributes | Details |
|---|---|
| Coagulation Factor Concentrates Market Size (2022) | US$ 7.8 Billion |
| Projected Market Value (2027F) | US$ 11.4 Billion |
| Global Market Growth Rate (2022 to 2027) | 7.8% CAGR |
| China Market Value (2027F) | US$ 2.5 Billion |
| United States Market Value (2022) | US$ 2 Billion |
| Germany Market Growth Rate (2022 to 2027) | 4.5% CAGR |
| Key Companies Profiled | CSL Behring; Shire; Kedrion S.P.A.; Grifols; Baxter International Inc.; Octapharma; LFB; Novo Nordisk A/S; Biotest; Green Cross Corporation; Shanghai RAAS Blood Products; Sanquin; Bio Product Laboratory; Medscape |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Sales Analysis of Coagulation Factor Concentrates (2017 to 2021) in Comparison to Market Forecasts (2022 to 2027)
The world has witnessed a prominent increase in the incidence of blood disorders over the past decade and this has led to a rise in demand for blood disorder treatments. Blood clotting factor concentrates play a crucial role in the treatment of different blood-related disorders and since the incidence of these disorders is on the rise, it is projected to boost demand for coagulation factor concentrates through 2027.
The market for coagulation factor concentrates is set to evolve at a high CAGR of 7.8% over the next five years. Increasing prevalence of Von Willebrand disease and disseminated intravascular coagulation (DIC) disorder is also projected to favor coagulation factor concentrates market growth over the years to come.
Rising adoption of prophylaxis treatment, growing incidence of hemophilia in newborns, upsurge in demand for hemophilia treatment, and high investments in healthcare research and development are other factors that could potentially uplift coagulation factor concentrates market growth over the next five years.
However, the high costs of blood disorder treatments and lack of awareness of blood disorders in developing economies are anticipated to have a hindering effect on the overall coagulation factor concentrates market potential.
Stringent regulatory mandates implemented by governments across the world to ensure patient safety are expected to slow down coagulation factor concentrates market growth across the forecast period.
A detailed assessment of the current as well as forecasted trends, restraints, and opportunities has been listed in this latest coagulation factor concentrates market research report by Fact.MR, a market research and competitive intelligence provider.
Which Factors are Anticipated to Shape the Coagulation Factor Concentrates Market?
“High Incidence of Hemophilia to Favor Clotting Factor Concentrate Demand”
The world has witnessed a notable increase in the prevalence of hemophilia and other blood disorders over the past few years and this trend is projected to follow a similar stance over the coming years and contribute to hemophilia treatment market size expansion.
Surging awareness of hemophilia and government initiatives to ensure affordable treatment are expected to propel the demand for coagulation factor concentrate therapies, plasma-derived coagulation factor concentrates, recombinant clotting factors, etc.
The coagulation factor concentrates market is also expected to benefit from the rising incidence of hemophilia and increasing disease awareness across the world. Coagulation factor XIII is a preferred choice in severe hemophilia treatment and is expected to witness a rise in demand owing to its better quality safety profile.
“High Cost of Blood Disorder Treatment to Hurt Coagulation Factor Concentrate Sales”
Blood disorder treatments are expensive in nature and this factor is expected to restrain the adoption of these treatment procedures, which is expected to negatively impact coagulation factor concentrate demand over the coming years. Moreover, the limited spending potential of patients in underdeveloped and developing economies and strict regulatory norms are also expected to have a hindering effect on the overall coagulation factor concentrates market potential through 2027.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How Will the Coagulation Factor Concentrates Industry Fare Across Geographies?
“North America & Europe to Spearhead Global Coagulation Factor Concentrates Market Growth”
The North America coagulation factor concentrates market is projected to account for a prominent market share in the global industry landscape throughout the forecast period.
Rapid adoption of novel treatments, the presence of developed healthcare infrastructure, and increasing investments in the healthcare research and development sector are expected to prominently augment coagulation factor concentrate demand in this region through 2027. The market for coagulation factor concentrates in Canada is predicted to evolve at a CAGR of 6.4% over the next five years.
Investments to improve healthcare infrastructure and increasing supportive government initiatives to boost awareness of blood disorders are expected to favor coagulation factor concentrate sales in Europe over the coming years. Key countries that coagulation factor concentrate suppliers should keep an eye out for in this region are France, Italy, Germany, and the United Kingdom.
The Germany coagulation factor concentrates market is anticipated to exhibit expansion at a CAGR of around 4.5% through 2027.
The Asia Pacific coagulation factor concentrates market is anticipated to be driven by an increasing blood-related disorder-affected patient pool and rising investments in healthcare infrastructure development. India is anticipated to be one of the key markets for coagulation factor concentrates owing to the high prevalence of hemophilia in the country.
The coagulation factor concentrates market in China is also expected to be highly opportune owing to the rising focus on healthcare infrastructure development and rising awareness of blood disorders. Demand for coagulation factor concentrates in China is anticipated to rise at a CAGR of 12% over the next five years and hold a value of US$ 2.5 billion by the end of 2027.
Country-wise Insights
What is the Demand Outlook for Coagulation Factor Concentrates in the United States?
“High Research Activity & Rising Availability of Blood Disorder Treatments to Drive U.S. Coagulation Factor Concentrate Sales”
The market for coagulation factor concentrates in the United States is anticipated to be driven by rising investments in the R&D sector and the growing prevalence of blood disorders. High healthcare expenditure and growing adoption of new treatments and therapies are expected to favor the bleeding disorders treatment market and subsequently drive coagulation factor concentrate demand as well.
An increase in government spending to promote research and development activity and initiatives to increase awareness of blood-related disorders are also expected to positively influence coagulation factor concentrates market potential in the U.S.
In 2022, sales of coagulation factor concentrates in the United States account for a revenue value of US$ 2 billion.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Type of Coagulation Factor Concentrate Will Exhibit High Demand?
“Coagulation Factor XIII to Lead Market Expansion Going Forward”
The global coagulation factor concentrates market, based on type, is segmented into coagulation factor IX, coagulation factor XIII, and other types.
Demand for coagulation factor XIII is anticipated to be higher than coagulation factor IX owing to its better safety profile and extensive use in the treatment of hemophilia A and hemophilia B diseases. Development of coagulation factor XIII involves virus inactivation similar to plasma-derived coagulation factor concentrates and hence results in a better quality safety profile.
This research on the coagulation factor concentrates industry also provides detailed insights on how demand for coagulation factor IX and other types of coagulation factors is expected to fare over the years to come.
Which End User Will Account for High Uptake of Coagulation Factor Concentrates?
“Research Laboratories to Witness High Demand for Clotting Factor Concentrates”
The coagulation factor concentrates market, based on end user, is bifurcated into hospitals & clinics, research laboratories, and academic institutions.
Investments in research and development in the healthcare industry have increased exponentially over the past few years owing to the rising prevalence of chronic blood disorders. The aforementioned factor is anticipated to drive demand for coagulation factor concentrates in research laboratories and the increasing establishment of research labs across the world is expected to further bolster demand through 2027.
Increasing awareness of blood disorder treatments and supportive initiatives to promote the same are expected to propel sales of coagulation factor concentrates in hospitals and clinics over the years to come.
Competitive Landscape
Coagulation factor concentrate providers are focusing on expanding their revenue generation capacity by getting new approval for their products from regulatory authorities.
- In July 2022, Novo Nordisk, a Danish multinational pharmaceutical organization, announced that the United States Food and Drug Administration (FDA) had approved REBINYN®, Coagulation Factor IX, GlycoPEGylated for regular prophylaxis in adults and children. REBINYN is a recombinant DNA-derived coagulation factor IX concentrate.
Other recent developments by key companies such as Baxter International Inc., Octapharma, LFB, Biotest, Green Cross Corporation, Shanghai RAAS Blood Products, and Sanquin have also been listed in this new market study on the coagulation factor concentrates industry.
Key Segments in Coagulation Factor Concentrates Industry Research
-
By Type :
- Coagulation Factor IX
- Coagulation Factor XIII
- Other Types
-
By End User :
- Hospitals & Clinics
- Research Laboratories
- Academic Institutions
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Type
- 9.1. Coagulation Factor IX
- 9.2. Coagulation Factor XIII
- 9.3. Other Types
- 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by End User
- 10.1. Hospitals & Clinics
- 10.2. Research Laboratories
- 10.3. Academic Institutions
- 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 15. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 16. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 17. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 18. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 19. Key and Emerging Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. CSL Behring
- 21.2. Shire
- 21.3. Kedrion S.P.A.
- 21.4. Grifols
- 21.5. Baxter International Inc.
- 21.6. Octapharma
- 21.7. LFB
- 21.8. Novo Nordisk A/S
- 21.9. Biotest
- 21.10. Green Cross Corporation
- 21.11. Shanghai RAAS Blood Products
- 21.12. Sanquin
- 21.13. Bio Product Laboratory
- 21.14. Medscape
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 08: Latin America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 11: Europe Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 14: South Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 17: East Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 20: Oceania Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2027, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2027, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2017 to 2021
Figure 02: Global Market Volume Forecast (in 000' Units), 2022 to 2027
Figure 03: Pricing Analysis (US$) Per Type, By Region, 2021
Figure 04: Pricing Analysis (US$) Per Type, By Region, 2021
Figure 05: Global Market Value Analysis (US$ Mn), 2017 to 2021
Figure 06: Global Market Value Forecast (US$ Mn), 2022 to 2027
Figure 07: Global Market Absolute $ Opportunity, 2022 to 2027
Figure 08: Global Market Share Analysis (%), By Type, 2022 to 2027
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2022 to 2027
Figure 10: Global Market Attractiveness Analysis by Type, 2022 to 2027
Figure 11: Global Market Share Analysis (%), By End User, 2022 to 2027
Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2022 to 2027
Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2027
Figure 14: Global Market Share Analysis (%), By Region, 2022 to 2027
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2022 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027
Figure 17: North America Market Value Share, By Type, 2022 (E)
Figure 18: North America Market Value Share, By End User, 2022 (E)
Figure 19: North America Market Value Share, By Country, 2022 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 21: North America Market Value Forecast (US$ Mn), 2022 to 2027
Figure 22: North America Market Attractiveness Analysis by Type, 2022 to 2027
Figure 23: North America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 24: North America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 25: Latin America Market Value Share, By Type, 2022 (E)
Figure 26: Latin America Market Value Share, By End User, 2022 (E)
Figure 27: Latin America Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 29: Latin America Market Value Forecast (US$ Mn), 2022 to 2027
Figure 30: Latin America Market Attractiveness Analysis by Type, 2022 to 2027
Figure 31: Latin America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 32: Latin America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 33: Europe Market Value Share, By Type, 2022 (E)
Figure 34: Europe Market Value Share, By End User, 2022 (E)
Figure 35: Europe Market Value Share, By Country, 2022 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2017 to 2021
Figure 37: Europe Market Value Forecast (US$ Mn), 2022 to 2027
Figure 38: Europe Market Attractiveness Analysis by Type, 2022 to 2027
Figure 39: Europe Market Attractiveness Analysis by End User, 2022 to 2027
Figure 40: Europe Market Attractiveness Analysis by Country, 2022 to 2027
Figure 41: South Asia Market Value Share, By Type, 2022 (E)
Figure 42: South Asia Market Value Share, By End User, 2022 (E)
Figure 43: South Asia Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 45: South Asia Market Value Forecast (US$ Mn), 2022 to 2027
Figure 46: South Asia Market Attractiveness Analysis by Type, 2022 to 2027
Figure 47: South Asia Market Attractiveness Analysis by End User, 2022 to 2027
Figure 48: South Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 49: East Asia Market Value Share, By Type, 2022 (E)
Figure 50: East Asia Market Value Share, By End User, 2022 (E)
Figure 51: East Asia Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 53: East Asia Market Value Forecast (US$ Mn), 2022 to 2027
Figure 54: East Asia Market Attractiveness Analysis by Type, 2022 to 2027
Figure 55: East Asia Market Attractiveness Analysis by End User, 2022 to 2027
Figure 56: East Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 57: Oceania Market Value Share, By Type, 2022 (E)
Figure 58: Oceania Market Value Share, By End User, 2022 (E)
Figure 59: Oceania Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2017 to 2021
Figure 61: Oceania Market Value Forecast (US$ Mn), 2022 to 2027
Figure 62: Oceania Market Attractiveness Analysis by Type, 2022 to 2027
Figure 63: Oceania Market Attractiveness Analysis by End User, 2022 to 2027
Figure 64: Oceania Market Attractiveness Analysis by Country, 2022 to 2027
Figure 65: Middle East and Africa Market Value Share, By Type, 2022 (E)
Figure 66: Middle East and Africa Market Value Share, By End User, 2022 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2017 to 2021
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2022 to 2027
Figure 70: Middle East and Africa Market Attractiveness Analysis by Type, 2022 to 2027
Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2022 to 2027
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2022 to 2027
Figure 73: U. S. Market Value Analysis (US$ Mn), 2022 & 2027
Figure 74: U. S. Market Value Share, By Type, 2022 (E)
Figure 75: U. S. Market Value Share, By End User, 2022 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2022 & 2027
Figure 77: Canada Market Value Share, By Type, 2022 (E)
Figure 78: Canada Market Value Share, By End User, 2022 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2022 & 2027
Figure 80: Mexico Market Value Share, By Type, 2022 (E)
Figure 81: Mexico Market Value Share, By End User, 2022 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2022 & 2027
Figure 83: Brazil Market Value Share, By Type, 2022 (E)
Figure 84: Brazil Market Value Share, By End User, 2022 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2022 & 2027
Figure 86: U. K. Market Value Share, By Type, 2022 (E)
Figure 87: U. K. Market Value Share, By End User, 2022 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2022 & 2027
Figure 89: Germany Market Value Share, By Type, 2022 (E)
Figure 90: Germany Market Value Share, By End User, 2022 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2022 & 2027
Figure 92: France Market Value Share, By Type, 2022 (E)
Figure 93: France Market Value Share, By End User, 2022 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2022 & 2027
Figure 95: Italy Market Value Share, By Type, 2022 (E)
Figure 96: Italy Market Value Share, By End User, 2022 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2022 & 2027
Figure 98: Spain Market Value Share, By Type, 2022 (E)
Figure 99: Spain Market Value Share, By End User, 2022 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2022 & 2027
Figure 101: Russia Market Value Share, By Type, 2022 (E)
Figure 102: Russia Market Value Share, By End User, 2022 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2022 & 2027
Figure 104: China Market Value Share, By Type, 2022 (E)
Figure 105: China Market Value Share, By End User, 2022 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2022 & 2027
Figure 107: Japan Market Value Share, By Type, 2022 (E)
Figure 108: Japan Market Value Share, By End User, 2022 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2022 & 2027
Figure 110: South Korea Market Value Share, By Type, 2022 (E)
Figure 111: South Korea Market Value Share, By End User, 2022 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2022 & 2027
Figure 113: India Market Value Share, By Type, 2022 (E)
Figure 114: India Market Value Share, By End User, 2022 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2022 & 2027
Figure 116: ASEAN Market Value Share, By Type, 2022 (E)
Figure 117: ASEAN Market Value Share, By End User, 2022 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2022 & 2027
Figure 119: Australia Market Value Share, By Type, 2022 (E)
Figure 120: Australia Market Value Share, By End User, 2022 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2022 & 2027
Figure 122: New Zealand Market Value Share, By Type, 2022 (E)
Figure 123: New Zealand Market Value Share, By End User, 2022 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2022 & 2027
Figure 125: GCC Countries Market Value Share, By Type, 2022 (E)
Figure 126: GCC Countries Market Value Share, By End User, 2022 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2022 & 2027
Figure 128: Turkey Market Value Share, By Type, 2022 (E)
Figure 129: Turkey Market Value Share, By End User, 2022 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2022 & 2027
Figure 131: South Africa Market Value Share, By Type, 2022 (E)
Figure 132: South Africa Market Value Share, By End User, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What valuation does the coagulation factor concentrates market enjoy?
The global coagulation factor concentrates market is valued at US$ 7.8 billion.
What value will the coagulation factor concentrates market reach by 2027?
The market for coagulation factor concentrates is projected to reach US$ 11.4 billion by 2027.
At what pace is the market expected to expand through 2027?
Global sales of coagulation factor concentrates are anticipated to evolve at 7.8% CAGR over the next five years.
What is the expected market valuation for China by the end of the forecast period?
The China coagulation factor concentrates market is set to be valued at US$ 2.5 billion by 2027.
At what CAGR will the market expand in Canada?
From 2022 to 2027, the Canada coagulation factor concentrates market is projected to expand at 6.4% CAGR.
Which key coagulation factor concentrate companies are profiled in this Fact.MR research?
Leading market players are CSL Behring, Shire, Kedrion S.P.A., Grifols, Baxter International Inc., Octapharma, LFB, Novo Nordisk A/S, Biotest, and Green Cross Corporation.
Coagulation Factor Concentrates Market